Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px
Document › Details

Protagen AG. (10/28/11). "Press Release: Protagen and Charles River Form Strategic Partnership".

Organisations Organisation Protagen AG
  Organisation 2 Charles River Laboratories International Inc. (NYSE: CRL)
  Group Charles River (Group)
Product Product proteomic services
Index term Index term Charles River–Protagen: proteomic services, 201110– collab marketing + sales alliance of Protagen services w Charles River preclinical services
Person Person Müllner, Stefan (Fundamenta Life-Sciences GmbH 201711 General Manager + Partner before Protagen –201610 CEO)
     


Protagen AG, Dortmund, a GMPcertified specialist in the characterization of protein drugs and Charles River Laboratories International, Inc., one of the world leading companies in highquality research models and preclinical and clinical support services, are pleased to announce a strategic Marketing & Sales alliance.

For Charles River Biopharmaceutical Services (BPS) the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles River BPS delivers client-focused solutions tailored to the specific testing and manufacturing requirements of biologics. Partnering with Protagen AG, an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis, will provide clients with services covering the entire range of protein analytics from detailed protein characterization to stability and lot release testing.

Working together, Charles River and Protagen can offer analytical experience and superior services through a single point of contact, providing more efficient project work and study design.

"The technology portfolio and the exceptional expertise of Charles River in the area of certified bioservices will synergistically complement the experience and competences of Protagen in the field of biotherapeutics and biosimilars. The customers in the pharmaceutical and biotech sector will profit from this alliance through the direct access to a comprehensive service portfolio", comments Dr. Stefan Müllner, CEO of Protagen AG.


About Protagen AG

Protagen AG is an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis. The innovations of Protagen are UNIarray®, a technology platform for the development of novel serum based diagnostics, as well as UNIchip®, a versatile product family of protein microarrays for faster development of antibodies.


Contact
Dr. Stefan Müllner
CEO
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: bettina.franz@protagen.de


Media Enquiries
Bettina Franz
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: info@protagen.de

   
Record changed: 2017-04-02

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px

More documents for Oncimmune (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px




» top